Log In
Print
BCIQ
Print
Print this Print this
 

TMC647055

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionNon-nucleoside HCV NS5B polymerase inhibitor
Molecular Target HCV NS5B polymerase
Mechanism of ActionNon-nucleoside polymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic HCV infection; Treat HCV infection
Regulatory Designation

U.S. - Fast Track (Treat chronic HCV infection)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today